KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Procter & Gamble (PG) Asset Writedowns and Impairment (2016 - 2023)

Procter & Gamble (PG) has disclosed Asset Writedowns and Impairment for 7 consecutive years, with $1.3 billion as the latest value for Q4 2023.

  • Quarterly Asset Writedowns and Impairment changed N/A to $1.3 billion in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $1.3 billion through Dec 2024, changed 0.0% year-over-year, with the annual reading at $1.3 billion for FY2024, N/A changed from the prior year.
  • Asset Writedowns and Impairment for Q4 2023 was $1.3 billion at Procter & Gamble, up from -$48.0 million in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $1.3 billion in Q4 2023, with the low at $1.3 billion in Q4 2023.